VITAPRO

This brand name is authorized in Nigeria.

Active ingredients

The drug VITAPRO contains one active pharmaceutical ingredient (API):

1	Ciprofloxacin UNII 4BA73M5E37 - CIPROFLOXACIN HYDROCHLORIDE
	Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination.
	Read more about Ciprofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-2170	Tablet	VITAPRO TAB 500 mg 1 X 10	101 RNW-PP-292400 VITAPRO CIPROFLOXACIN TABLETS USP 500MG Ciprofloxacin Hydrochloride USP 582.0mg Equivalent to Ciprofloxacin 500mg Maize Starch 302.22mg Sodium Starch Glycolate 7.84mg Sodium Methyl Paraben 15.04mg Sodium Propyl Paraben 0.12mg Purified Talc 12.16mg Magnesium Stearate 11.37mg Colloidal Anhydrous Silica 1.50mg Sodium Carboxyl Methyl Cellulose 6.85mg Sodium Lauryl Sulphate 1.63mg Purified water Q.S Instacoat 16.63mg Apr-70 Drugs Nigerian Products 10tab POM 1 10/27/2022 SAGAR VITACEUTICALS NIGERIA LTD., PLOT 2, LADIPO OLUWOLE STREET 9022977711 suptpharm@svnl.in Sagar Vitaceuticals Nigeria Limited, Plot 2, Ladipo Oluwole Street, Off Oba Akran Avenue, Ikeja, Lagos, Nigeria, Nigeria	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA02	Ciprofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-2170